Literature DB >> 10551419

Characterisation of a novel HLA-A pseudogene, HLA-BEL, with significant sequence identity with a gorilla MHC class I gene.

F Williams1, M D Curran, D Middleton.   

Abstract

During the development of an HLA-A polymerase chain reaction using sequence-specific oligonucleotide probes (PCR-SSOP) method for the identification of HLA-A*24 and -A*30 alleles, group amplification resulted in the formation of an unusual PCR product in certain individuals. This fragment was approximately 900 bp smaller than the expected product and was also detected in some non-HLA-A*24- and -A*30-positive individuals acting as negative controls for the group specific amplification. Nucleotide sequence analysis of this product identified it as a unique class I gene sequence displaying homology to both primate and human class I A-locus genes. The entire gene was amplified using PCR and the complete DNA sequence information from exon 1 to exon 8, including introns, was determined. A recombination event was identified which results in the fusion of intron 2 with intron 3, causing a deletion of the intervening exon 3 sequence. In addition, there are two cytosine insertions in the poly-cytosine stretch at the start of exon 4 which cause a frameshift and premature termination. The exon 1 and 2 sequences most closely align with the gorilla allele A*0501, displaying only five mismatches. PCR analysis has established that the gene is associated with the following HLA-A types: HLA-A*3001, -A*3301, -A*3303, -A*6802, -A*2901, -A*0203, -A*0205 and -A*31012. Reverse transcription (RT)-PCR analysis of individuals containing this gene failed to detect any mRNA transcription, suggesting that this is a previously undescribed non-expressed class I pseudogene which we have provisionally named HLA-BEL. Its unique gene structure gives a possible insight into the evolutionary pathway that created HLA class I genes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10551419     DOI: 10.1034/j.1399-0039.1999.540405.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  6 in total

Review 1.  Nomenclature for factors of the HLA system, 2010.

Authors:  S G E Marsh; E D Albert; W F Bodmer; R E Bontrop; B Dupont; H A Erlich; M Fernández-Viña; D E Geraghty; R Holdsworth; C K Hurley; M Lau; K W Lee; B Mach; M Maiers; W R Mayr; C R Müller; P Parham; E W Petersdorf; T Sasazuki; J L Strominger; A Svejgaard; P I Terasaki; J M Tiercy; J Trowsdale
Journal:  Tissue Antigens       Date:  2010-04

2.  Although divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLA-A*02 have overlapping peptide-binding repertoires.

Authors:  Michael Gleimer; Angela R Wahl; Heather D Hickman; Laurent Abi-Rached; Paul J Norman; Lisbeth A Guethlein; John A Hammond; Monia Draghi; Erin J Adams; Sean Juo; Roxana Jalili; Baback Gharizadeh; Mostafa Ronaghi; K Christopher Garcia; William H Hildebrand; Peter Parham
Journal:  J Immunol       Date:  2011-01-05       Impact factor: 5.422

3.  Very long haplotype tracts characterized at high resolution from HLA homozygous cell lines.

Authors:  Paul J Norman; Steve J Norberg; Neda Nemat-Gorgani; Thomas Royce; Jill A Hollenbach; Melissa Shults Won; Lisbeth A Guethlein; Kevin L Gunderson; Mostafa Ronaghi; Peter Parham
Journal:  Immunogenetics       Date:  2015-07-22       Impact factor: 2.846

4.  A Microsatellite in the Coding Sequence of HLA-A/B Is a Mutation Hotspot in Colon Cancer With Microsatellite Instability.

Authors:  William J Raab; Arabella Mazzocchi; Paolo Radice; Debashis Sahoo; Chiara Castelli; Piero Dalerba
Journal:  Gastroenterology       Date:  2021-10-12       Impact factor: 22.682

5.  Gorilla MHC class I gene and sequence variation in a comparative context.

Authors:  Jörg B Hans; Richard A Bergl; Linda Vigilant
Journal:  Immunogenetics       Date:  2017-03-22       Impact factor: 2.846

Review 6.  Two to Tango: Co-evolution of Hominid Natural Killer Cell Receptors and MHC.

Authors:  Emily E Wroblewski; Peter Parham; Lisbeth A Guethlein
Journal:  Front Immunol       Date:  2019-02-19       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.